Accupril and X-ray gastrointestinal tract abnormal - a phase IV clinical study of FDA data

Summary:

X-ray gastrointestinal tract abnormal is reported only by a few people who take Accupril.

The phase IV clinical study analyzes which people take Accupril and have X-ray gastrointestinal tract abnormal. It is created by eHealthMe based on reports of 12,983 people who have side effects while taking Accupril from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 23, 2023

12,983 people reported to have side effects when taking Accupril.
Among them, 1 person (0.01%) has X-ray gastrointestinal tract abnormal.


What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,223 Accupril users for its effectiveness, alternative drugs and more.

What is X-ray gastrointestinal tract abnormal?

X-ray gastrointestinal tract abnormal is found to be associated with 243 drugs and 136 conditions by eHealthMe.

Number of Accupril and X-ray gastrointestinal tract abnormal reports submitted per year:

Could Accupril cause X-ray gastrointestinal tract abnormal?

Gender of people who have X-ray gastrointestinal tract abnormal when taking Accupril *:

  • female: 100 %
  • male: 0.0 %

Age of people who have X-ray gastrointestinal tract abnormal when taking Accupril *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Accupril *:

  1. Prilosec: 1 person, 100.00%
  2. Plendil: 1 person, 100.00%
  3. Macrodantin: 1 person, 100.00%
  4. Levothroid: 1 person, 100.00%
  5. Fosrenol: 1 person, 100.00%
  6. Folic Acid: 1 person, 100.00%
  7. Evista: 1 person, 100.00%
  8. Cozaar: 1 person, 100.00%
  9. Allopurinol: 1 person, 100.00%

Common side effects people have besides X-ray gastrointestinal tract abnormal *:

  1. Computerised Tomogram Abdomen Abnormal: 1 person, 100.00%

Common conditions people have *:

  1. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and have X-ray gastrointestinal tract abnormal?

Check whether X-ray gastrointestinal tract abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was X-ray gastrointestinal tract abnormal and when was it recovered:

Expand to all the drugs that have ingredients of quinapril hydrochloride:

Alternative drugs to, pros and cons of Accupril:

Common Accupril side effects:

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

X-ray gastrointestinal tract abnormal treatments and more:

COVID vaccines that are related to X-ray gastrointestinal tract abnormal:

All the drugs that are associated with X-ray gastrointestinal tract abnormal:

All the conditions that are associated with X-ray gastrointestinal tract abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride (the active ingredients of Accupril) and Accupril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: